Thompson Davis & Co’s Verastem VSTM Stock Holding History

Thompson Davis & Co’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-100	Closed	-$6K	–	1087
2017 Q3	$6K	Buy	+100	New	+$4.72K	0.01%	824

Other funds holding VSTM

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Thompson Davis & Co's VSTM Position: Q4 2017 in Review

Thompson Davis & Co sold out of Verastem (VSTM) in Q4 2017, closing a stake of 100 shares — an estimated $6K sold.

Thompson Davis & Co first reported a position in VSTM in Q3 2017 and held it in 1 quarter. The position peaked at $6K in Q3 2017. 88 funds tracked by Wall St. Rank hold VSTM as of Q4 2017.

Thompson Davis & Co reported no remaining Verastem position as of Q4 2017 after selling out during the quarter.
Thompson Davis & Co sold 100 Verastem shares in Q4 2017, an estimated $6K.
Thompson Davis & Co first reported a position in Verastem in Q3 2017 and held it in 1 quarter.
Thompson Davis & Co's Verastem position peaked at $6K in Q3 2017.
88 funds tracked by Wall St. Rank held Verastem as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.